Google AdWords is one of the most established digital advertising platforms in the world, and is used by organisations of many different sizes to achieve their marketing goals. This module will outline the opportunities that Google AdWords provides for HIV prevention.
This publication aims to support the strengthening of antenatal screening programmes for HIV, hepatitis B, syphilis and rubella susceptibility in the general population and in groups identified as vulnerable to mother-to-child-transmission in the EU/EEA.
This document provides guidance for developing innovative and effective communication strategies to promote a culture of lower risk behaviour in the MSM community in the European Union and European Economic Area.
This document updates the 2009 ECDC guidance on chlamydia control in Europe. The aim of this guidance is to support Member States to develop, implement or improve strategies for chlamydia control.
This guidance, based on a systematic review of the literature and expert opinion, suggests that there is good evidence to ensure that some key components are considered for inclusion in national and sub-national public health programmes in countries in Europe.
The number of new HIV cases diagnosed annually in Cyprus has been on the rise since 2005: more than 50 new cases of HIV were diagnosed every year from 2011 to 2013. This report addresses this issue and provides options on how Cyprus can respond to the epidemic.
At the request of the Ministry of Health in Riga, a team of experts from ECDC and the European Monitoring Centre for Drugs and Drug Addiction paid a technical visit to Latvia on 2–4 September 2014.
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
This response plan is designed to prevent the spread of multidrug-resistant Neisseria gonorrhoeae (MDR NG) in the EU/EEA in the context of the possible emergence of untreatable gonorrhoea